Redcare Pharmacy NV

RDC

NL0012044747

Drug Retailers

Market Closed - Xetra Other stock markets 11:44:18 2024-04-29 EDT			Pre-market 02:52:16
128.5 ^EUR	-1.15%		128.8	+0.19%

04-26	REDCARE PHARMACY : Deutsche Bank reiterates its Buy rating	ZD
04-26	REDCARE PHARMACY : Hauck & Aufhauser keeps its Buy rating	ZD

SHOP APOTHEKE EUROPE NV : Jefferies remains its Buy rating

July 23, 2021 at 02:28 am

Jefferies analyst Alexander Thiel maintains his Buy rating on the stock. The target price remains set at EUR 201.

Latest news about Redcare Pharmacy NV

REDCARE PHARMACY : Deutsche Bank reiterates its Buy rating	04-26	ZD
REDCARE PHARMACY : Hauck & Aufhauser keeps its Buy rating	04-26	ZD
REDCARE PHARMACY : Receives a Buy rating from Baader Bank	04-25	ZD
REDCARE PHARMACY : Warburg Research reaffirms its Neutral rating	04-25	ZD
REDCARE PHARMACY : Jefferies maintains a Buy rating	04-25	ZD
Redcare Pharmacy NV Reports Earnings Results for the First Quarter Ended March 31, 2024	04-25	CI
Transcript : Redcare Pharmacy NV, Q1 2024 Earnings Call, Apr 25, 2024	04-24
REDCARE PHARMACY : Receives a Buy rating from Baader Bank	04-24	ZD
Swiss online drug delivery firm DocMorris reports slight miss in Q1 sales	04-16	RE
REDCARE PHARMACY : Gets a Buy rating from Jefferies	04-12	ZD
REDCARE PHARMACY : Warburg Research remains Neutral	04-05	ZD
REDCARE PHARMACY : Deutsche Bank maintains a Buy rating	04-05	ZD
REDCARE PHARMACY : Warburg Research gives a Neutral rating	04-04	ZD
REDCARE PHARMACY : Baader Bank maintains a Buy rating	04-04	ZD
REDCARE PHARMACY : Hauck & Aufhauser keeps its Buy rating	04-04	ZD
REDCARE PHARMACY : Jefferies reaffirms its Buy rating	04-04	ZD
REDCARE PHARMACY : Deutsche Bank reiterates its Buy rating	03-22	ZD
REDCARE PHARMACY : Buy rating from Hauck & Aufhauser	03-15	ZD
REDCARE PHARMACY : Warburg Research reaffirms its Neutral rating	03-15	ZD
REDCARE PHARMACY : Jefferies reaffirms its Buy rating	03-14	ZD
REDCARE PHARMACY : Hauck & Aufhauser reiterates its Buy rating	03-12	ZD
REDCARE PHARMACY : Berenberg maintains a Buy rating	03-12	ZD
REDCARE PHARMACY : Deutsche Bank reiterates its Buy rating	03-11	ZD
REDCARE PHARMACY : Deutsche Bank reaffirms its Buy rating	03-06	ZD
REDCARE PHARMACY : Hauck & Aufhauser reiterates its Buy rating	03-06	ZD

Redcare Pharmacy NV is a company based in the Netherlands that retails pharmaceutical products online. The Company focuses on non-prescription medication (OTC), as well as on pharmacy-related beauty and personal care (BPC) products. The Company is active in Belgium, Spain, Italy, France, Austria, the Netherlands and Germany.

Sector

Drug Retailers

Calendar

2024-07-29 - Q2 2024 Earnings Release

Related indices

MDAX

More about the company

Income Statement Evolution

More financial data

Analysis / Opinion

Shop Apotheke Europe N.V. : Growth still not profitable

March 09, 2023 at 11:32 am

More Strategies

Ratings for Redcare Pharmacy NV

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

Last Close Price

128.5 EUR

Average target price

155.2 EUR

Spread / Average Target

+20.76%

Consensus

EPS Revisions

Estimates Revisions

Quarterly revenue - Rate of surprise

Company calendar

Sector Other Drug Retailers

	1st Jan change	Capi.
REDCARE PHARMACY NV	-2.36%	2.78B
JD HEALTH INTERNATIONAL INC.	-30.18%	11.21B
ALIBABA HEALTH INFORMATION TECHNOLOGY LIMITED	-30.42%	6.23B
YIFENG PHARMACY CHAIN CO., LTD.	+7.42%	6B
MATSUKIYOCOCOKARA & CO.	-10.01%	5.89B
NAHDI MEDICAL COMPANY	-0.73%	4.72B
CORPORATIVO FRAGUA, S.A.B. DE C.V.	+53.60%	4.32B
CLICKS GROUP LIMITED	-9.42%	3.77B
DASHENLIN PHARMACEUTICAL GROUP CO., LTD.	-13.25%	3.4B
WELCIA HOLDINGS CO., LTD.	-5.84%	3.03B

Other Drug Retailers

Redcare Pharmacy NV

Equities

RDC

NL0012044747

Drug Retailers

SHOP APOTHEKE EUROPE NV : Jefferies remains its Buy rating

Latest news about Redcare Pharmacy NV

Chart Redcare Pharmacy NV

Company Profile

Income Statement Evolution

Analysis / Opinion

Ratings for Redcare Pharmacy NV

Analysts' Consensus

EPS Revisions

Quarterly revenue - Rate of surprise

Sector Other Drug Retailers